• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away faster

2

Meet a 71-year-old who retired as a radiologist and professor, and now runs a banana-skewer business: ‘I never want to retire. Why would you do that?’

3

China suffers another setback in effort to de-dollarize global finance as anchor in the greenback's dominance quietly exits Beijing's payment scheme

1

Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away faster

2

Meet a 71-year-old who retired as a radiologist and professor, and now runs a banana-skewer business: ‘I never want to retire. Why would you do that?’

3

China suffers another setback in effort to de-dollarize global finance as anchor in the greenback's dominance quietly exits Beijing's payment scheme
Healthblood pressure medicine

Another Blood Pressure Medication is Being Recalled

By
Emily Price
Emily Price
Down Arrow Button Icon
By
Emily Price
Emily Price
Down Arrow Button Icon
January 8, 2019, 2:12 PM ET
Google source logo
Add Fortune on Google for similar content.

Yet another blood pressure medication has been recalled over concerns that it contains a small amount of a carcinogen.

Torrent Pharmaceuticals has recalled eight more lots of losartan potassium tablets, adding to the two lots that it recalled last month, USA Today reports. That means the company has recalled a total of 10 lots of the drug.

Torrent is recalling lots of the losartan product that contain N-nitrosodiethylamine (NDEA) above the acceptable intake levels set by the FDA. The FDA notes on its site that NDEA occurs naturally in certain foods as well as drinking water, air pollution, and industrial processes.

The recalled drug is used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy and for the treatment of nephropathy in Type 2 diabetic patients. All of the recalled medication is sold in packaged bottles. The FDA has listed the batch and lot numbers as well as the expiration dates of the impacted bottles on its site.

If you’re someone who takes the drug, the FDA recommends continuing to take it despite the recall, because abruptly going off the drug could be more harmful than the carcinogens found in it.

Patients who do take losartan should contact their doctor or pharmacist about an alternative treatment.

Losartan also isn’t the only blood pressure drug to have been recalled over the past few months. Other drugs including valsartan, amlopidine, irbesartan, and hydrochlorothiazide have also been recalled in recent months.

About the Author
By Emily Price
See full bioRight Arrow Button Icon

Latest in Health


Most Popular

Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    Latest in Health


    Most Popular

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.